10 is the total number of securities ABG Innovation Capital Partners III GP Ltd has owned. The longest ABG Innovation Capital Partners III GP Ltd has owned a single stock is 12 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| SYBX | SYNLOGIC INC | 12 | 12 | 0.26% | 13.68% | 33.77% | Q4 2020 | Q3 2023 | 12 |
| AADI BIOSCIENCES INC | 9 | 9 | 17.55% | 26.35% | 37.25% | Q3 2021 | Q3 2023 | 9 | |
| IDRA | IDERA PHARMACEUTICALS INC | 9 | 9 | 0.04% | 1.27% | 2.41% | Q4 2020 | Q4 2022 | 9 |
| GNCA | GENOCEA BIOSCIENCES INC | 8 | 8 | 0.27% | 11.48% | 32.06% | Q4 2020 | Q3 2022 | 8 |
| NABRIVA THERAPEUTICS PLC | 7 | 7 | 0.04% | 0.86% | 2.28% | Q4 2020 | Q2 2022 | 7 | |
| CSTL | CASTLE BIOSCIENCES INC | 6 | 6 | 54.91% | 64.21% | 77.21% | Q2 2022 | Q3 2023 | 6 |
| LUNG | PULMONX CORP | 5 | 5 | 0.67% | 13.08% | 33.86% | Q4 2020 | Q4 2021 | 5 |
| ARPO | AERPIO PHARMACEUTICALS... | 3 | 3 | 0.23% | 0.92% | 2.26% | Q4 2020 | Q2 2021 | 3 |
| AVIR | ATEA PHARMACEUTICALS INC | 1 | 1 | 64.92% | 77.97% | 91.01% | Q4 2020 | Q2 2021 | 2 |
| ATEA PHARMACEUTICALS INC | 1 | 1 | 80.08% | 80.08% | 80.08% | Q1 2021 | Q1 2021 | 1 | |
Download | |||||||||
The securities at the top of the list , including SYNLOGIC INC, AADI BIOSCIENCES INC, and IDERA PHARMACEUTICALS INC, are the highest-conviction holdings of ABG Innovation Capital Partners III GP Ltd.
The conviction is calculated by counting the number of quarters a security has been reported by ABG Innovation Capital Partners III GP Ltd. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that ABG Innovation Capital Partners III GP Ltd owns currently or has owned in the past.